EUA
Quest Diagnostics RC COVID-19+Flu RT-PCR
FDA Emergency Use Authorization · Quest Diagnostics Nichols Institute · Dec 14, 2021
Key facts
| Product | Quest Diagnostics RC COVID-19+Flu RT-PCR |
|---|---|
| Company | Quest Diagnostics Nichols Institute |
| Product type | Real-time RT-PCR, Multi-analyte, Home Collection, Multiple Targets |
| Date | Dec 14, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 10–99 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: